Korsana Biosciences (KRSA) Common Equity (2018 - 2025)
Korsana Biosciences (KRSA) reported Common Equity of $9.09 million for Q4 2025, up 2.7% from $8.85 million a year earlier but down 4.7% from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) Common Equity (2018 - 2025) Analysis & Trends
Dating back to Q1 2018, Korsana Biosciences' Common Equity record includes 32 quarters.
- Common Equity has a five-year compound annual growth rate of -31.3% (FY2020 to FY2025).
- By year, Common Equity came in at $8.85 million in FY2024 (-21.6%), $11.29 million in FY2023 (+8.0%), $10.45 million in FY2022 (-78.3%) and $48.25 million in FY2021 (-18.9%).
- Five-year quarterly Common Equity spans a low of $3.93 million in Q1 2023 and a high of $65.22 million in Q2 2021.
- Year over year, Common Equity gained in four of the last eight quarters, with growth averaging 21.3%.
- The high point for year-over-year Common Equity in five years was Q1 2024 (growth of 152.8%); the low point was Q1 2023 (a decline of 89.4%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $9.54 million (Q3 2025), $8.57 million (Q2 2025) and $8.78 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Korsana Biosciences | 16.27 Mn | 1.82 Mn | - | 9.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.09 Mn |
| Sep 30, 2025 | 9.54 Mn |
| Jun 30, 2025 | 8.57 Mn |
| Mar 31, 2025 | 8.78 Mn |
| Dec 31, 2024 | 8.85 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 8.78 Mn |
| Mar 31, 2024 | 9.92 Mn |
| Dec 31, 2023 | 11.29 Mn |
| Sep 30, 2023 | 12.87 Mn |
| Jun 30, 2023 | 5.15 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 10.45 Mn |
| Sep 30, 2022 | 16.52 Mn |
| Jun 30, 2022 | 25.36 Mn |
| Mar 31, 2022 | 37.03 Mn |
| Dec 31, 2021 | 48.25 Mn |
| Sep 30, 2021 | 56.39 Mn |
| Jun 30, 2021 | 65.22 Mn |
| Mar 31, 2021 | 48.43 Mn |
API Access
Korsana Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();